Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
Blog
Topical Treatments - Their Impact on Drug Spend and Utilization
Workers' Comp
Article
StateWatch: Bill Review May 2018
Keep current with new legislation and its potential effect on your organization.
Mitchell
News Release
Hawaii Legislature Sends Opioid Limits Bill to Governor
The Hawaii Legislature passed SB2244 and sent the legislation to Governor Ige for his signature on May 3, 2018.
Mitchell
Article
Insurtech: Improving Consumer Experiences and Relationships
Technology is one of the hottest topics in insurance, as Insurtech innovations continue to disrupt the industry.
Mitchell
News Release
Oklahoma Joins Growing Chorus of States Limiting Opioids
By Brian Allen, VP of Government Affairs
Workers' Comp
Article
Quarterly Drug Update: Pharmacy Drug Spend
In this quarter's report, we give you insight into cost efficient medications and what expenses to monitor. CompPharma's